UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

Clinical Microbiology Reviews, 2009-10, Vol.22 (4), p.582-610

2009

Volltextzugriff (PDF)

Mechanisms of β-lactam resistance among Pseudomonas aeruginosa

Current pharmaceutical design, 2013, Vol.19 (2), p.209-222

2013

Volltextzugriff (PDF)

Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model: Impact of Area under the Curve/MIC Ratios on Eradication

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.69-74

LISTER, Philip D

2002

Volltextzugriff (PDF)

blaKPC RNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-Negative Pathogens

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3936-3938

2011

Volltextzugriff (PDF)

AmpC and OprD Are Not Involved in the Mechanism of Imipenem Hypersusceptibility among Pseudomonas aeruginosa Isolates Overexpressing the mexCD-oprJ Efflux Pump

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4763-4766

2005

Volltextzugriff (PDF)

Increased Expression of ampC in Pseudomonas aeruginosa Mutants Selected with Ciprofloxacin

Antimicrobial Agents and Chemotherapy, 2007-08, Vol.51 (8), p.2997-3000

2007

Volltextzugriff (PDF)

Carbapenems in the USA: focus on doripenem

Expert review of anti-infective therapy, 2007-10, Vol.5 (5), p.793-809

Lister, Philip D

2007

Volltextzugriff (PDF)

Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1118-1123

1999

Volltextzugriff (PDF)

bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens

Antimicrobial agents and chemotherapy, 2011-08, Vol.55 (8), p.3936-3938

2011

Volltextzugriff (PDF)

Effect of drug treatment options on the mobility and expression of blaKPC

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2779-2785

2013

Volltextzugriff (PDF)

Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin

Antimicrobial Agents and Chemotherapy, 1999-04, Vol.43 (4), p.882-889

1999

Volltextzugriff (PDF)

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance

FEMS microbiology letters, 2004-07, Vol.236 (1), p.137-143

2004

Volltextzugriff (PDF)

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

Journal of antimicrobial chemotherapy, 2009-08, Vol.64 (2), p.294-300

2009

Volltextzugriff (PDF)

Production of KPC-2 alone does not always result in β-lactam MICs representing resistance in gram-negative pathogens

Journal of clinical microbiology, 2012-12, Vol.50 (12), p.4183-4184

2012

Volltextzugriff (PDF)

The role of pharmacodynamic research in the assessment and development of new antibacterial drugs

Biochemical pharmacology, 2006-03, Vol.71 (7), p.1057-1065

Lister, Philip D.

2006

Volltextzugriff (PDF)

Levofloxacin-Imipenem Combination Prevents the Emergence of Resistance among Clinical Isolates of Pseudomonas aeruginosa

Clinical infectious diseases, 2005-02, Vol.40 (Supplement-2), p.S105-S114

2005

Volltextzugriff (PDF)

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Journal of antimicrobial chemotherapy, 1999, Vol.43 (1), p.79-86

1999

Volltextzugriff (PDF)

Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

Diagnostic microbiology and infectious disease, 2002-09, Vol.44 (1), p.43-49

Lister, Philip D

2002

Volltextzugriff (PDF)

Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1610-1619

1998

Volltextzugriff (PDF)

Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs

Journal of antimicrobial chemotherapy, 2006-05, Vol.57 (5), p.999-1003

2006

Volltextzugriff (PDF)

Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae

Postgraduate medicine, 2008-09, Vol.120 (3 Suppl 1), p.46-52

Lister, Philip D

2008

Volltextzugriff (PDF)

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

Journal of antimicrobial chemotherapy, 2001-06, Vol.47 (6), p.811-818

2001

Volltextzugriff (PDF)

Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones

Journal of antimicrobial chemotherapy, 2003-01, Vol.51 (1), p.199-202

Lister, Philip D

2003

Volltextzugriff (PDF)

Pharmacodynamics of Moxifloxacin and Levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacodynamic Model

Clinical infectious diseases, 2001-03, Vol.32 (Supplement-1), p.S33-S38

Lister, P D

2001

Volltextzugriff (PDF)

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital

Diagnostic microbiology and infectious disease, 2004-09, Vol.50 (1), p.43-50

2004

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(95)

Sprache

Englisch
(94)
Katalanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

Mechanisms of β-lactam resistance among Pseudomonas aeruginosa

Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model: Impact of Area under the Curve/MIC Ratios on Eradication

blaKPC RNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-Negative Pathogens

AmpC and OprD Are Not Involved in the Mechanism of Imipenem Hypersusceptibility among Pseudomonas aeruginosa Isolates Overexpressing the mexCD-oprJ Efflux Pump

Increased Expression of ampC in Pseudomonas aeruginosa Mutants Selected with Ciprofloxacin

Carbapenems in the USA: focus on doripenem

Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens

Effect of drug treatment options on the mobility and expression of blaKPC

Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

Production of KPC-2 alone does not always result in β-lactam MICs representing resistance in gram-negative pathogens

The role of pharmacodynamic research in the assessment and development of new antibacterial drugs

Levofloxacin-Imipenem Combination Prevents the Emergence of Resistance among Clinical Isolates of Pseudomonas aeruginosa

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs

Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones

Pharmacodynamics of Moxifloxacin and Levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacodynamic Model

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital

Suchergebnisse filtern